MMC Ventures, which invests in AI companies, has published its State of AI 2019 report, revealing rapid recent progress in AI adoption in healthcare.
The European Commission is launching a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans living with a rare disease.
The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country. Finnish citizens are now able to retrieve medicine prescribed by a doctor in Finland from a pharmacy in Estonia with ePrescriptions.
WeHealth by Servier and Pathmaker Neurosystems have formed a partnership to develop and commercialise Pathmaker's MyoRegulator device, a non-invasive treatment for spasticity.
JPND, the EU's neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.